Latest news

Thumbnail image for £373k awarded to earlier pancreatic cancer diagnosis research

£373k awarded to earlier pancreatic cancer diagnosis research

The funding announcement coincides with the launch of Cancer Research UK’s “Right Now” campaign, which aims to show both the realities of the disease and the positive impact research and improved treatments can have on people’s lives.

18th November 2019

Thumbnail image for ABPI launches general election manifesto

ABPI launches general election manifesto

The industry body hopes that the proceeding Government will “shape one of our country’s most valuable assets: an incredible pharmaceutical industry that employs tens of thousands and invests billions in research.”

18th November 2019

Thumbnail image for FDA ‘yes’ for Fetroja

FDA ‘yes’ for Fetroja

The company has also submitted a marketing authorisation application for the drug to the European Medicines Agency.

15th November 2019

Thumbnail image for AZ bags EU approval for Qtrilmet

AZ bags EU approval for Qtrilmet

The therapy, a once-daily oral medicine, was initially approved in the US in May 2019 under the name Qternmet XR.

15th November 2019

Thumbnail image for NICE ‘OK’ for Sativex in MS

NICE ‘OK’ for Sativex in MS

The organisation updates its MS Guideline to state that Sativex should be offered to treat spasticity in people with the disorder.

14th November 2019

Thumbnail image for  AZ releases positive anifrolumab data

AZ releases positive anifrolumab data

Only one drug has been approved for the indication in the lat 60 years, GlaxoSmithKline’s Benlysta (belimumab), which was also the first-ever biologic treatment for the disease.

14th November 2019

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download